---
$id: https://graph.org.ai/products/commodity/51111642
$type: Product
source: UNSPSC
code: "51111642"
title: "Irinotecan"
class: "51111600"
classTitle: "Antimetabolites"
family: "51110000"
familyTitle: "Antineoplastic agents"
segment: "51000000"
segmentTitle: "Pharmaceutical Products incl. Contraceptives and Vaccines"


---

# Irinotecan

**UNSPSC Code**: 51111642
**Class**: [Antimetabolites](Antimetabolites.mdx)
**Family**: [Antineoplastic agents](../Antineoplastic agents.mdx)
**Segment**: [Pharmaceutical Products incl. Contraceptives and Vaccines](../../Pharmaceutical Products incl. Contraceptives and Vaccines.mdx)

This classification denotes a camptothecin analogue with the molecular formula C33H38N4O6, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier 7673326042, chemically known as irinotecan, cpt-11 but generally known as irinotecan, which bears US NIH Compound Identifier 60838. European Medicines Agency schedules Irinotecan in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB08295MIG. The term IRINOTECAN is an International Non-Proprietary Name or INN (see WHO INN reference publication, Volume 5, No. 3 1991, List 31). World Health Organization schedules irinotecan in its Anatomical Therapeutic Chemical (ATC) Classification. IRINOTECAN is scheduled in the U.S. International Trade Commission's Harmonized Tariff System (HTS) Pharmaceutical Appendix. Most nations schedule irinotecan under HS 29399900 and SITC 54149. As of Q4 2014, IRINOTECAN remains the US FDA Preferred Term for this commodity. Irinotecan bears US NLM identifiers UMLS ID C0123931 and NCI Concept Code C62040. SMILES: O(C(=O)N1CCC(N2CCCCC2)CC1)C1CC2C(C3CN4C(C3NC2CC1)CC1C(O)(CC)C(=O)OCC1C4=O)CC.

